4
Stegeman, Raymond, Nijman, Maaike, Breur, Johannes M P J, Groenendaal, Floris, Haas, Felix, Derks, Jan B, Nijman, Joppe, van Beynum, Ingrid M, Taverne, Yannick J H J, Bogers, Ad J J C, Helbing, Willem A, de Boode, Willem P, Bos, Arend F, Berger, Rolf M F, Accord, Ryan E, Roes, Kit C B, de Wit, G Ardine, Jansen, Nicolaas J G, Benders, Manon J N L
Veröffentlicht in: CRUCIAL trial consortium , Stegeman , R , Nijman , M , Breur , J M P J , Groenendaal , F , Haas , F , Derks , J B , Nijman , J , van Beynum , I M , Taverne , Y J H J , Bogers , A J J C , Helbing , W A , de Boode , W P , Bos , A F , Berger , R M F , Accord , R E , Roes , K C B , de Wit , G A , Jansen , N J G & Benders , M J N L 2022 , ' CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL) : study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial ' , Trials , vol. 23 , no. 1 , 174 . https://doi.org/10.1186/s13063-022-06098-y;
2022
9
Baak, Lisanne M., Wagenaar, Nienke, van der Aa, Niek E., Groenendaal, Floris, Dudink, Jeroen, Tataranno, Maria Luisa, Mahamuud, Ubah, Verhage, Cornelia H., Eijsermans, Rian M.J.C., Smit, Liesbeth S., Jellema, Reint K., de Haan, Timo R., ter Horst, Hendrik J., de Boode, Willem P., Steggerda, Sylke J., Prins, Henk Jan, de Haar, Colin G., de Vries, Linda S., van Bel, Frank, Heijnen, Cobi J., Nijboer, Cora H., Benders, Manon J.N.L.
Veröffentlicht in: Baak , L M , Wagenaar , N , van der Aa , N E , Groenendaal , F , Dudink , J , Tataranno , M L , Mahamuud , U , Verhage , C H , Eijsermans , R M J C , Smit , L S , Jellema , R K , de Haan , T R , ter Horst , H J , de Boode , W P , Steggerda , S J , Prins , H J , de Haar , C G , de Vries , L S , van Bel , F , Heijnen , C J , Nijboer , C H & Benders , M J N L 2022 , ' Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN) : a first-in-human, open-label intervention study ' , The Lancet Neurology , vol. 21 , no. 6 , pp. 528-536 . https://doi.org/10.1016/S1474-4422(22)00117-X;
2022